A Phase 2 Trial of Neoadjuvant Modified FOLFIRINOX Chemotherapy for Resectable Pancreatic Adenocarcinoma

Clinical trial NCT05066802 · UNKNOWN

Trial details

NCT number: NCT05066802
Sponsor: Yonsei University
Status: UNKNOWN
Phase: Phase 2
Study type: INTERVENTIONAL

Resectable Pancreatic Adenocarcinoma

Start date: 2020-05-11
Primary completion: 2022-05-31
Enrollment: 27

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.